Lack of MMP-9 expression is a marker for poor prognosis in Dukes’ B colorectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6890
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Lack of MMP-9 expression is a marker for poor prognosis in Dukes’ B colorectal cancer ; volume:12 ; number:1 ; day:7 ; month:12 ; year:2012 ; pages:1-7 ; date:12.2012
BMC clinical pathology ; 12, Heft 1 (7.12.2012), 1-7, 12.2012
- Creator
-
Koskensalo, Selja
- Contributor
-
Hagström, Jaana
Linder, Nina
Lundin, Mikael
Sorsa, Timo
Louhimo, Johanna
Haglund, Caj
SpringerLink (Online service)
- DOI
-
10.1186/1472-6890-12-24
- URN
-
urn:nbn:de:1111-2016071635986
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Koskensalo, Selja
- Hagström, Jaana
- Linder, Nina
- Lundin, Mikael
- Sorsa, Timo
- Louhimo, Johanna
- Haglund, Caj
- SpringerLink (Online service)
Other Objects (12)
Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer
Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma
Podocalyxin is a marker of poor prognosis in colorectal cancer
MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis
Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognosis of invasive breast cancer
CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer
Low expression of LOC285194 is associated with poor prognosis in colorectal cancer
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer
Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis
DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis
Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer
Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma
Podocalyxin is a marker of poor prognosis in colorectal cancer
MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis
Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognosis of invasive breast cancer
CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer
Low expression of LOC285194 is associated with poor prognosis in colorectal cancer
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer
Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis
DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis
Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer
Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma
Podocalyxin is a marker of poor prognosis in colorectal cancer
MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis
Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognosis of invasive breast cancer
CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer
Low expression of LOC285194 is associated with poor prognosis in colorectal cancer
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer
Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis
DEK over expression as an independent biomarker for poor prognosis in colorectal cancer